446 related articles for article (PubMed ID: 33920929)
1. Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.
Philippens IHCHM; Langermans JAM
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33920929
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.
Philippens IH; Ormel PR; Baarends G; Johansson M; Remarque EJ; Doverskog M
J Alzheimers Dis; 2017; 55(1):101-113. PubMed ID: 27662314
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint.
Pepeu G
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):193-209. PubMed ID: 11263752
[TBL] [Abstract][Full Text] [Related]
6. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease.
Martinez B; Peplow PV
Neural Regen Res; 2019 Jul; 14(7):1158-1176. PubMed ID: 30804241
[TBL] [Abstract][Full Text] [Related]
8. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
More SS; Vince R
ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
10. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
11. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunities.
Haque RU; Levey AI
Proc Natl Acad Sci U S A; 2019 Dec; 116(52):26224-26229. PubMed ID: 31871211
[TBL] [Abstract][Full Text] [Related]
13. Reducing the progression of Alzheimer's disease in Down syndrome patients with micro-dose lithium.
Priebe GA; Kanzawa MM
Med Hypotheses; 2020 Apr; 137():109573. PubMed ID: 31986471
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's disease: new prospects in therapy and applied experimental models].
Kubis AM; Janusz M
Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208
[TBL] [Abstract][Full Text] [Related]
15. The Role of Selected Bioactive Compounds in the Prevention of Alzheimer's Disease.
Grodzicki W; Dziendzikowska K
Antioxidants (Basel); 2020 Mar; 9(3):. PubMed ID: 32168776
[TBL] [Abstract][Full Text] [Related]
16. Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.
Taipa R; Sousa AL; Melo Pires M; Sousa N
J Alzheimers Dis; 2016 May; 53(2):403-17. PubMed ID: 27176075
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
[TBL] [Abstract][Full Text] [Related]
18. The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases.
Philippens IH; 't Hart BA; Torres G
Drug Discov Today; 2010 Dec; 15(23-24):985-90. PubMed ID: 20732446
[TBL] [Abstract][Full Text] [Related]
19. Interplay Between Microglia and Alzheimer's Disease-Focus on the Most Relevant Risks: APOE Genotype, Sex and Age.
Chen Y; Hong T; Chen F; Sun Y; Wang Y; Cui L
Front Aging Neurosci; 2021; 13():631827. PubMed ID: 33897406
[TBL] [Abstract][Full Text] [Related]
20. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
